From reaction to resolution: The future of allergy treatment
Twelve-year-old Lauren Eglite was thrilled to attend a Notre Dame football game with her father, Erik, in 2017, even though her acute peanut allergy demands constant vigilance.
She was even more excited when the stadium’s brand-new video board aired an NBC Fighting For story about Basar Bilgicer’s research into blocking peanut allergens from triggering immune system overreactions. She asked her father, a drug company executive and Notre Dame business school alumnus, if this might be an opportunity to get involved with a solution to a condition that had complicated her life since childhood.
“I remember to this day her looking at that screen and turning to me,” Dr. Erik Eglite said. “She said, ‘Daddy, can I meet him? I really want to do something about it.’ This kid actually did that.”
It was a bold request, but Bilgicer didn’t hesitate after Dr. Eglite reached out. The Notre Dame professor of chemical and biomolecular engineering invited the whole Eglite family to his lab and explained his complex research in overwhelming detail.
The coincidence of that video playing to the right audience of two has led to immense mutual benefits. Nearly eight years later, Bilgicer and Eglite have partnered to form a company called Artin Immunology that aims to turn Bilgicer’s peanut allergy research into a blockbuster drug.
Originally published by at news.nd.edu on July 01, 2025.
Latest Research
- New Study Highlights Mother-Child Link for Anemia in The GambiaAnemia is a "silent epidemic." It affects nearly 2 billion people globally, yet many people ignore its symptoms. Typically caused by the consumption of iron-deficient foods, anemia develops gradually. Its symptoms—such as fatigue, weakness, and shortness of breath—are frequently dismissed or misattributed.
- Megan McDermott joins ND–IBM Tech Ethics Lab as new Notre Dame directorThe Notre Dame–IBM Technology Ethics Lab, a critical component of the Institute for Ethics and the Common Good (ECG) and the Notre…
- Jenkins Center for Virtue Ethics receives grant to advance love-based ethical frameworkThe University of Notre Dame has received a $10 million grant from the John Templeton Foundation to support a project titled Love and Social Transformation: Empowering Scholars and Social Innovators to Develop the Love Ethic.
- ND-GAIN releases latest Country Index updateThe lastest update to the University of Notre Dame’s Global Adaptation Initiative's (ND-GAIN) Country Index is now live. The ND-GAIN team will release a second Country Index update in late Fall, which includes…
- In sub-Saharan Africa, 1 in 6 cancer medications found to be defectiveSerious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.
- Belfast conference honors legacy of Irish art historian S.B. KennedyMore than 80 people gathered at the Ulster Museum and Queen’s University Belfast on May 22-23 for the conference “New Histories of Irish Art and Modernism.”
